Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

The purpose of this study was to evaluate the activity, measured in terms of progression-free survival (PFS) and response rates, of 1,3-bis(chloroethyl)-1-nitrosourea (BCNU) plus temozolomide in adult patients with recurrent glioblastoma multiforme. The phase 2 dose and schedule for this trial was B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Prados, Michael D., Yung, W.K. Alfred, Fine, Howard A., Greenberg, Harry S., Junck, Larry, Chang, Susan M., Nicholas, M. Kelly, Robins, H. Ian, Mehta, Minesh P., Fink, Karen L., Jaeckle, Kurt A., Kuhn, John, Hess, Kenneth R., Schold, S. Clifford
Format: Artigo
Sprache:Inglês
Veröffentlicht: Duke University Press 2004
Schlagworte:
Clinical Investigations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871975/
https://ncbi.nlm.nih.gov/pubmed/14769138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000309
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge